Trial Profile

A Randomized, Placebo Controlled, Phase1 Study to Assess the Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 27 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Uproleselan (Primary) ; Enoxaparin sodium
Indications Deep vein thrombosis
Focus Adverse reactions; First in man; Pharmacokinetics
Sponsors GlycoMimetics

Most Recent Events

24 Apr 2017 Status changed from active, no longer recruiting to completed.
06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology
08 Dec 2015 Interim results of this study (n = 18) and results of NCT02168595 study presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com